GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » EPS without NRI

SMO Clinplus Co (SZSE:301257) EPS without NRI : ¥1.79 (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co EPS without NRI?

SMO Clinplus Co's earnings per share without non-recurring items for the three months ended in Mar. 2024 was ¥0.31. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.79.

During the past 12 months, SMO Clinplus Co's average earnings per share (NRI) Growth Rate was 46.00% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 29.40% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 16.80% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for SMO Clinplus Co's EPS without NRI or its related term are showing as below:

SZSE:301257' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 1.2   Med: 27.35   Max: 32.1
Current: 29.4

During the past 7 years, SMO Clinplus Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 32.10% per year. The lowest was 1.20% per year. And the median was 27.35% per year.

SZSE:301257's 3-Year EPS without NRI Growth Rate is ranked better than
80.7% of 171 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.5 vs SZSE:301257: 29.40

SMO Clinplus Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.29. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.68.

SMO Clinplus Co's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.29. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.69.


SMO Clinplus Co EPS without NRI Historical Data

The historical data trend for SMO Clinplus Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co EPS without NRI Chart

SMO Clinplus Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial 0.91 0.67 1.08 0.95 1.45

SMO Clinplus Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.50 0.51 0.47 0.31

Competitive Comparison of SMO Clinplus Co's EPS without NRI

For the Diagnostics & Research subindustry, SMO Clinplus Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMO Clinplus Co's PE Ratio without NRI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SMO Clinplus Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where SMO Clinplus Co's PE Ratio without NRI falls into.



SMO Clinplus Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SMO Clinplus Co  (SZSE:301257) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


SMO Clinplus Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of SMO Clinplus Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


SMO Clinplus Co (SZSE:301257) Business Description

Traded in Other Exchanges
N/A
Address
No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Executives
Lai Chun Bao Director
Ma Lin Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines